aTyr Pharma, Inc.
NASDAQ:LIFE
1.9 (USD) • At close June 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -50.389 | -45.343 | -33.777 | -16.23 | -23.763 | -34.515 | -48.207 | -57.855 | -47.973 | -24.35 | -20.014 | -12.86 |
| Afschrijvingen & Amortisatie
| 2.741 | 1.695 | 1.304 | 1.266 | 1.366 | 0.746 | 0.713 | 0.9 | 0.869 | 0.829 | 0.714 | 0.54 |
| Uitgestelde Inkomstenbelasting
| -3.262 | 0 | 0.006 | 0.113 | -0.312 | -0.243 | 0.014 | 0.733 | 1.086 | 0.469 | 0.211 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 2.6 | 2.154 | 1.614 | 1.465 | 1.783 | 0 | 6.784 | 5.029 | 4.856 | 1.791 | 0.155 | 0.166 |
| Verandering in Werkkapitaal
| 15.012 | -0.833 | -2.588 | -2.261 | 0.206 | -1.448 | -1.73 | -1.353 | 3.278 | -1.25 | 1.849 | 0 |
| Vorderingen
| 9.054 | -11.923 | 1.604 | -1.939 | 0.058 | -0.053 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 11.923 | 0 | 1.939 | -0.058 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 3.262 | 6.741 | 0.047 | 1.763 | 0.162 | -2.058 | -2.491 | -0.932 | 3.944 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 2.696 | -7.574 | -4.239 | -4.024 | 0.044 | 0.61 | 0.761 | -0.421 | -0.666 | -1.043 | 0.323 | 0 |
| Overige Niet-Contante Posten
| 0.077 | 0.441 | 0.366 | 0.346 | 0.707 | 0.966 | 0.062 | -0.315 | 1.087 | -0.313 | -0.226 | 0.942 |
| Kasstroom uit Operationele Activiteiten
| -33.221 | -41.886 | -33.075 | -15.301 | -20.013 | -31.063 | -42.364 | -52.861 | -36.797 | -22.824 | -17.311 | -11.378 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -4.215 | -1.641 | -0.192 | -0.202 | -0.079 | -0.594 | -1.312 | -0.6 | -0.664 | -0.249 | -0.644 | -0.598 |
| Netto Overnames
| 0.015 | 0.179 | 0.05 | 0.018 | 0.051 | -0.261 | 0.014 | 0.531 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -106.977 | -42.118 | -126.506 | -21.066 | -40.647 | -40.299 | -77.672 | -28.089 | -109.445 | -5.397 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 91.05 | 90.825 | 35.082 | 28.15 | 45.6 | 78.065 | 51.347 | 62.216 | 38.115 | 3.4 | 0 | 0 |
| Overige Investeringsactiviteiten
| -15.912 | 48.886 | -91.374 | 7.102 | 5.004 | 0.261 | -0.014 | -0.531 | -71.33 | -1.997 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -20.127 | 47.245 | -91.566 | 6.9 | 4.925 | 37.172 | -27.637 | 33.527 | -71.994 | -2.246 | -0.644 | -0.598 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 66.624 | 5.517 | 110.025 | 6.447 | 9.336 | 0.379 | 42.477 | 0.143 | 76.902 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0.105 | 0 | 0 | 0 | 0 | 0.036 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 66.23 | 5.451 | 110.025 | 16.143 | 1.336 | -4.238 | 52.704 | 4.697 | 147.917 | 2.512 | 50.737 | 1.658 |
| Kasstroom uit Financieringsactiviteiten
| 66.23 | 5.451 | 110.025 | 16.143 | 1.336 | -4.238 | 52.704 | 4.697 | 147.917 | 2.512 | 50.737 | 1.658 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 12.563 | 10.81 | -14.616 | 7.742 | -13.752 | 1.871 | -17.297 | -14.637 | 39.126 | -22.558 | 32.782 | -10.318 |
| Kaspositie aan het Einde van de Periode
| 22.544 | 13.146 | 2.336 | 16.952 | 9.21 | 22.962 | 21.091 | 38.388 | 53.025 | 13.899 | 36.457 | 3.675 |